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Summary 
It has been established that at least some Vf117 + T  cells interact with an endogenous super- 
antigen encoded by the murine retrovirus, Mtv-9. To analyze the role of major histocompatibility 
complex (MHC) dass II molecules in presenting the Mtv-9 encoded superantigen, vSAG-9 to 
Vf117 + hybridomas, a panel of nine hybridomas was tested for their ability to respond to A20/2J 
(H-2  a) and LBK (H-2  a) cells which had been transfected with the vSAG-9 gene. Whereas some 
of the hybridomas recognized vSAG-9 exclusively in the context of H-2  ~, other hybridomas 
recognized vSAG-9 exclusively in the context of H-2  a or in the context of both H-2  d and H-2  ~. 
These results suggest that: (a) the class II MHC molecule plays a direct role in the recognition 
of retroviral superantigen by T cells, rather than serving simply as a platform for presentation; 
and,  (b) it is likely that components of the TCR other than Vfl are involved in the vSAG- 
9/TCR/class  II interaction. 
S 
uperantigens are defined by their ability to stimulate high 
frequencies of T  cells based predominantly on the V~/ 
component of the TCR.  Bacterial superantigens are toxins 
produced by certain strains of bacteria, whereas endogenous 
superantigens are encoded by the 3' LTR of the mouse mam- 
mary tumor virus (MMTV)  (1-3). 
T  cell recognition of superantigen differs from recogni- 
tion of conventional antigen in two fundamental ways. First, 
in contrast to recognition of conventional antigen, which is 
dependent upon contributions of both the cr  and/3 chains 
of the TCR to the combining site, T cell recognition of su- 
perantigen is mediated primarily through the V~ element 
of the receptor. Second, T  cell recognition of superantigen 
is not classically  MHC  restricted (1-3). 
The Mtv-9 encoded superantigen (vSAG-9) interacts with 
most  murine  V~5.1 +,  VB5.2 +,  VB11 +,  V~12 +,  and 
V~17 +  T  cells  (4,  5,  and  D.  L.  Woodland  and  M. A. 
Blackman, unpublished results).  Here, we investigate the role 
of MHC class II molecules in presenting this endogenous 
superantigen by examining the response of a panel of Vf117 + 
T cell hybridomas to Mtv-9 3'LTR transfectants that express 
vSAG-9 in  the context of either H-2  d or H-2  a.  It is  sur- 
prising that hybridomas are shown to distinguish between 
vSAG-9 presented on different MHC alleles, resulting in a 
form of MHC restriction. This observation contrasts strongly 
with the view that T cell responses to retroviral superantigens 
are independent of the MHC  haplotype of the presenting 
cell, and suggests that non-V~ (DE, JB, Vol, Jo  0  elements 
of the TCR influence its interaction with the MHC class 
IIAuperantigen complex. 
Materials and Methods 
Cells.  The  V/317+/CD4 +  hybridomas  were  derived  from 
C57/L  (H-2 b)  T  cells  as  described  previously  (6).  11-40 
(V/311 +/CD4 +) and KE8 (VBS.1  §  +) are T cell hybridomas 
that react with the Mtv-9 YLTR encoded superantigen, vSAG-9, 
as detailed elsewhere (4, 5). The Mtv-9 TLTR, under the control 
of the human B-actin promoter, was transfeeted into A20 or LBK, 
as previously described (5, and Lund, et al., manuscript submitted 
for publication). For this study, we used two A20/2J transfectants, 
1H10 and 2C3, and two LBK transfectants, 3G9 and 3H3. A20/2J 
is derived from BALB/c (I-A  a, LE  a) mice, and LBK is an in vitro- 
adapted subclone of CH12 that is derived from B10.H-2,H-4bp- 
Wts (I-A  k, I-E  k) mice. 
Stimulation Assays.  10  s responding hybridomas were cultured 
either with 10  s B cell tumors (A20/2J,  LBK, or Mtv-9 YLTR 
transfectants), 106 LPS/Ib4-treated spleen cells (7), or immobi- 
lized anti-TCR antibody in duplicate 250-/xl cultures. Supematants 
were tested for II.-2, as previously described (7). Responses of the 
hybridomas to staphylococcal enterotoxin D (SED) (Toxin Tech- 
nology, Sarasota, FL) was determined in the standard stimulation 
assay by including varying concentrations (10, 1, 0.1, or 0.01 #g/ml) 
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were done in the standard stimulation assay  by adding purified an- 
tibodies (5 gg/ml) to the cultures. The mAbs 10-3.6 (anti-I-AB  k) 
and 14.4.4S (anti-I-E) were generously  provided  by Dr. John Freed 
(National  Jewish Center for Immunology,  Denver, CO) and MKD6 
(anti-I-A  d) was purchased from Becton Dickinson & Co.  (San 
Jose, CA). All of  these antibodies  brightly stained  the relevant trans- 
fectants and parental B cell lines, were capable of inhibiting II.-2 
production in appropriate controls, and were not nonspecifically 
toxic (data not shown). 
Results 
MHC-restricted  Recognition  of vSAG-9  by  Vf117 + Hybrid- 
omas.  We had previously shown that at least some V~17 + 
hybridomas respond to a superantigen encoded by the retroviral 
integrant Mtv-9 (vSAG-9) (5). To further investigate the in- 
teraction, we screened a panel of 41 V~17 +  CD4 + T call hy- 
bridomas  derived  from  C57L  (H-2  b)  mice  for  reactivity 
against spleen cells from B10.D2  (H-2  d, Mtv-9*) or B10.BR 
(H-2  k, Mtv-9 +) mice (6). Approximately half of the hybrid- 
omas (20 of  41) were reactive to B10.D2 and/or B10.BR spleen 
cells. However, whereas some of the hybridomas responded 
exclusively to B10.BR spleen cells (13 of 20),  other hybrid- 
omas responded either exclusively to B10.D2 spleen ceUs (3 
of 20), or to spleen cells from both strains (4 of 20; data not 
shown). This result was surprising, because  T  cell interac- 
tion with other endogenous superantigens had not revealed 
an MHC-restricted pattern of reactivity. 
To eliminate the possibility that these findings were due 
to the expression  of multiple retroviral superantigens by the 
spleen cells, we analyzed the responses of a selected panel of 
nine V/~17  +/CD4 + hybridomas to two sets of transfectants 
expressing vSAG-9 in the context of H-2  a or H-2  a. The re- 
sponse of the hybridomas to the transfectants correlated directly 
with the MHC-restricted reactivity observed on B10.D2 and 
B10.BR spleen cells (Table 1). Thus, some of the hybridomas 
(2B23-10, -11, and -12) were H-2  a (AkEk)-restricted,  in that 
they responded to vSAG-9 presented on LBK transfectants 
but not A20/2J transfectants. Conversely, other hybridomas 
(2B23-40 and -53) were H-2d-(AaE  a) restricted, in that they 
responded to vSAG-9 presented by A20/2J transfectants but 
not LBK transfectants. The hybridoma, 2B23-18, responded 
to vSAG-9 presented on both types of transfectants, and this 
dual reactivity did not segregate in subclones (data not shown). 
Some of the hybridomas (2B23-8,  -26, and -30) failed to re- 
spond to any of the transfectants, despite the fact that they 
secreted I1.-2 in response to immobilized anti-VB17 antibody, 
and they responded to IE + spleen cells from mice expressing 
MHC haplotypes other than H-2  k and H-2  d (see Discussion 
section). The MHC-restricted pattern of vSAG-9 recogni- 
tion by V~17 + hybridomas cannot be explained by a failure 
of vSAG-9 to bind to class II molecules on either H-2  a or 
Table  1.  Response  of VflS.1 §  V~II ~ and  V~17 § Hybridomas  to vSAG-9  Presented on  Spleen  Cells,  A20/2J  Transfectants, 
and LBK  Transfectants* 
A20 transfectants  LBK transfectants 
Spleen cells~  (H-2  d)  (H-2  ~) 
Immobilized 
Hybridoma  (V3)  B10.D2  B10.BR  A20  1H10  2C3  LBK  3H3  3G9  KJ23  (anti-Vf117)  Jfl Usage~ 
None  -  -  *  ......... 
11-40  (11)  112  325  -  129  47  -  126  346  ND  ND 
KE8  (5.1)  56  200  -  800  653  -  1,166  1,211  ND  ND 
2B23-10  (17)  -  253  ....  133  373  340  2.1 
2B23-11  (17)  -  65  ....  20  427  560  1.2 
2B23-12  (17)  -  20  ....  320  1,013  1,920  2.6 
2B23-40  (17)  267  -  -  87  80  -  -  -  187  2.1 
2B23-53  (17)  840  -  -  820  987  -  -  -  1,080  2.2/2.3 
2B23-18  (17)  90  445  -  230  507  -  1,333  1,333  1,066  2.3 
2B23-8  (17)  ........  100  2.6 
2B23-26  (17)  ........  400  2.5 
2B23-30  (17)  ........  1,920  1.2 
* Hybridoma responses are presented as IL-2 secretion in U/ml as outlined in Materials and Methods.  Responses below the level of detection  (<10 
U/ml) are indicated by a dash (-). Data represent  the mean responses of at hast three independent experiments. 
Spleen cells were  pretreated  with LPS and IL-4 to enhance vSAG-9 expression as described by Woodland et al. (7). 
s j~ usage by the V~17 + hybridomas  was previously determined by Biackman et aL (6). 
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good  presenters  of vSAG-9  to  11-40  (V/$11 +)  and  KE8 
(V~5.1+),  hybridomas  previously  shown  to  recognize 
vSAG-9. Thus, the reactivity of VB17 + T  cells to endoge- 
nous superantigens showed a strong and unexpected influence 
of the MHC haplotype of the presenting cells. 
Class II Presentation of vSAG-9.  To clarify exactly which 
class II molecules are involved in the presentation of the Mtv-9 
superantigen, we tested the ability of various MHC dass II 
specific antibodies to inhibit the response of VB17 + hybrid- 
omas to vSAG-9 presented by H-2  a (1H10) or H-2  a (3G9) 
transfectants (Table 2). Those hybridomas that responded to 
vSAG-9 in the context of H-2  a (11-40, KE8, 2B23-18, -40, 
and -53) were strongly inhibited by antibodies specific for 
bE  d (14-4-4), but not I-A  a (MKD6), indicating that this re- 
sponse is specific for the I-E  d molecule. Those hybridomas 
that responded to vSAG-9 in  the context of H-2  a (11-40, 
KE8, 2B23-10, -11, -12, and -18) showed a surprising restric- 
tion pattern. The response of these hybridomas to the H-2  ~ 
transfectant (3G9) was partially blocked by antibodies specific 
for either I-A  k (10-3.6) or I-E  k (14-4-4S), and was completely 
blocked by combinations of these two antibodies. This pat- 
tern was observed consistently in several experiments, and 
suggests that these hybridomas recognize vSAG-9 presented 
in association with both I-A  k and I-E  k. This observation was 
unexpected since VB17 + T  cell responses have been geneti- 
cally mapped to the I-E molecule. 
j~ Does Not Correlate with the MHC Restriction Pattern of 
vSAG-9 Reactivity of V[317  + Hybridomas.  Although the VB 
element of the TCK dominates vSAG-9 reactivity of VB17 + 
T cells, some other elements of the receptor may be respon- 
sible for conferring the property of MHC restriction. How- 
ever, comparison of TCK J/~ usage (previously determined 
by Blackman, et al., reference 6) with the MHC-restricted 
pattern of vSAG-9 recognition revealed no obvious correla- 
tion (Table 1). For example, two hybridomas, 2B23-40 and 
2B23-10,  both use the same JB2.1 element in the construc- 
tion of their receptors, despite the fact that they have very 
different  restriction  patterns  (2B23-40  is  I-E  a  restricted 
whereas 2B23-10 is I-A  k and I-E  k restricted). Similarly, hy- 
bridomas with identical restriction patterns  (2B23-11  and 
2B23-12) use very different JB elements (JB1.2  and J/~2.6, 
respectively). 
MHC-restricted Recognition of Bacterial Superantigens.  Be- 
cause there are functional similarities between superantigens 
from  retroviruses  and  bacteria,  we  tested  the  ability  of 
V/$17 + hybridomas to recognize the bacterial superantigen 
SED  presented on  either  H-2  d (A20/2J)  or  H-2  a (LBK) 
(Table 3). All of the VB17 + hybridomas and 11-40 (V~11 +) 
responded to SED presented by either A20/2J or LBK, ir- 
respective of their MHC restriction for vSAG-9. The inability 
of KE8 to recognize SED presented on any MHC haplotype 
is consistent with the fact that murine VBS.1 + T  cells do 
not recognize this superantigen (1). 
Table  2.  Inhibition  of Hybridoma Responses to vSAG-9 by mAbs Specific  for MHC Class II Molecules* 
Inhibitory antibodies* 
MKD6 +  10-3.6 + 
MKD6  10-3.6  14-4-4s  14-4-4s  14-4-4s 
Hybridoma  Stimulator  None  (A  d)  (A  k)  (Ed/E  k)  (Ad,Ed/E  k)  (A~,Ea/E~) 
11-40  1H10  160  320  80  -  *  -  - 
KE8  1H10  1,280  1,280  1,280  -  -  - 
2B23-40  1H10  640  640  640  -  -  - 
2B23-53  1H10  2,560  2,560  2,560  -  -  - 
2B23-18  1H10  640  640  640  -  -  - 
11-40  3G9  5,120  5,120  160  80  160  - 
KE8  3G9  5,120  5,120  320  320  640  - 
2B23-10  3G9  5,120  5,120  640  640  1,280  - 
2B23-11  3G9  320  320  .... 
2B23-12  3G9  >5,120  >5,120  2,560  320  320  - 
2B  23-18  3G9  5,120  2,560  1,280  640  640  20 
* The responses of a panel of V~5.1  +, V/311  +, and V/317  + hybridomas  to either a LBK transfectaut  (3G9) (H-2~) or an A20/2J transfectant  (1H10) 
(H-2  a) were measured in the presence  of purified mAbs specific  for various MHC class II molecules  as described in Materials and Methods. Hybrido- 
ma responses are presented as U/ml IL-2 and responses  below the level of detection  (<10 U/ml) are indicated  by a dash ( - ). The data are representa- 
tive examples of three or more independent experiments. 
* The relevent specificities  of each antibody are shown under each antibody's name. 
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A20/2J or LBK* 
A20/2J + SED*  LBK  +  SED* 
Immobilized H57-597 
Hybridoma  10  1  0.1  0  1  0.1  0.01  0  (anti-TCR) 
None  -  *  ........ 
11-40  >1,280  >1,280  >1,280  -  >1,280  >1,280  >1,280  -  >1,280 
KE8  ........  >1,280 
2B23-10  640  -  -  -  1,280  160  -  -  640 
2B23-11  1,280  640  -  -  1,280  640  40  -  640 
2B23-12  >1,280  >1,280  20  -  >1,280  >1,280  160  -  >1,280 
2B23-40  >1,280  320  -  -  >1,280  1,280  -  -  1,280 
2B23-53  1,280  160  -  -  >1,280  640  -  -  >1,280 
2B23-18  1,280  40  -  -  >1,280  640  -  -  640 
2B23-8  1,280  -  -  -  1,280  160  -  -  640 
2B23-26  >1,280  1,280  -  -  >1,280  1,280  20  -  1,280 
2B23-30  >1,280  -  -  -  >1,280  40  -  -  >1,280 
* Hybridoma responses are presented as U/ml IL-2 secreted as described in Materials and Methods. Responses below the level of detection (<10 
U/ml) are indicated by a dash ( - ). The data are a representative example of three independent experiments. No hybridomas responded to SED 
(10 #g/ml) in the absence of presenting cells. 
* SED concentrations are in #g/ml. 
Discussion 
Whereas the requirement for class II in the presentation 
of superantigens  has been established,  the molecular details 
of the interaction are unclear. It has been suggested that both 
retroviral and bacterial superantigens function by simultane- 
ously binding to the class II molecule of the presenting cell 
and the VB element of the responding T cell (2). In this model, 
the MHC class II molecule acts simply as a generic support 
for the superantigen,  which is consistent with the observa- 
tions that superantigen  stimulation  of individual  T  cells is 
essentially independent  of the class II haplotype of the pre- 
senting cells.  The general hierarchy of presentation  of bac- 
terial and retroviral superantigens  to T  cells can largely be 
explained by differences in the  affinity of the  superantigen 
for a particular MHC  class II allele. However, in several ex- 
amples,  the responses  of individual  hybridomas and clones 
to bacterial  superantigens  have exhibited  MHC  allelic and 
isotypic preference that cannot be attributed simply to differ- 
ences  in  superantigen  binding  to  MHC  (8-10).  The  data 
presented  in  this  paper extend  these  observations  to  show 
that T cell responses to endogenous superantigens can be MHC 
restricted. 
We have studied  the  response  of V~17 +  hybridomas  to 
a series of transfectants which express the MMTV  superan- 
tigen,  vSAG-9, and found,  unexpectedly,  that there was an 
MHC haplotype-restricted pattern of recognition.  Whereas 
some hybridomas responded to vSAG-9 presented exclusively 
by H-2  d transfectants,  others responded exclusively to H-2  a 
transfectants.  The MHC-restricted response patterns cannot 
be simply attributed  to (a) differences in levels of class II or 
vSAG-9 expression on the transfectants; (b) preferential binding 
of vSAG-9 to class II molecules of one or the other haplo- 
type; or (c), influence of adhesion molecule interactions such 
as LFA-1/intercellular  adhesion  molecule-I,  since both  the 
H-2  a  and  H-2  '  transfectants  and  spleen  cells  are  good 
presenters  of vSAG-9 to  appropriate  hybridomas. 
The simplest explanation for the MHC-restricted interac- 
tion between Vf117 + hybridomas and vSAG-9 + transfectants 
is that there is a direct interaction either between the TCR 
and the class II molecule itself, or between the TCR and an 
MHC haplotype-specific dominant peptide presented on class 
II. This is consistent with the idea that superantigen binding 
may force the intimate contact of the TCR with class II, as 
originally proposed by Janeway et al. (2).  It is possible that 
superantigen recognition is generally not MHC restricted be- 
cause the interactions between superantigen  and class II, or 
between  superantigen  and  TCR  are strong,  rendering  the 
forced intimacy between TCR and class II irrelevant.  How- 
ever, if either of the interactions is weak, the contact between 
non-Vfl elements of the TCR with polymorphic determinants 
on the class II molecule may either stabilize, or interfere with, 
the TCR/class II/superantigen complex, resulting in MHC- 
biased patterns of recognition. Thus, the finding that recog- 
nition of vSAG-9, but not SED, by V~17 + hybridomas was 
MHC restricted, could be explained either by the differences 
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the differences in strength of interaction of V317 elements 
with vSAG-9/class II and with SED/class II. 
The finding that the recognition of vSAG-9 by V317 + 
hybridomas is MHC restricted  contrasts  starkly with data 
on the recognition of other endogenous retroviral superan- 
tigens by T cells. For example, Mls-1 is presented by several 
different MHC haplotypes, and most Mls-1 reactive hybrid- 
omas and clones respond strongly to Mls-1/H-2  k and Mls- 
1/H-2  a (3,  11-13). In terms of the model described above, 
a likely possibility is that Mls-1 has a higher affinity for the 
class II molecule and/or V3 element than vSAG-9, such that 
an interaction between class II and TCR does not influence 
the specificity. 
The data presented here suggest that the TCK directly in- 
teracts with the MHC class II molecule during the recogni- 
tion of vSAG-9. This interaction likely involves non-VB ele- 
ments of the TCR since the Vf117 element is encoded by 
a single member gene family. Although analysis of  J3 usage 
did not reveal an obvious role for J/~ in the MHC restriction 
of these cells, it is possible that the DB element D3J/~ junc- 
tion, or ct chain elements control the MHC specificity. Al- 
ternatively, the MHC specificity may be determined  by com- 
binatorial  determinants contributed by both the ot and 
chains, obscuring a simple correlation  with individual ele- 
ments of the TCR.  We have independent data that shows 
a role for the TCK-oe chain in recognition of Mls-1 by a panel 
of hybridomas bearing an identical (transgenic) V38.1 + beta 
chain (14). 
One intriguing result of our studies is that 3 of 3 of the 
k-restricted  hybridomas recognized vSAG-9 in the context 
of both I-E  k and I-A  k. This contrasts with genetic analyses 
that have suggested that only I-E molecules are able to mediate 
the clonal elimination of V317 + cells (15). However, it is 
possible that the original  genetic analyses were misleading 
because only the few strains that express V317 could be ex- 
amined, and because the stronger deletion on I-E masked the 
weaker contribution of I-A. Recently, the V317-expressing 
TCR locus has been backcrossed onto a number of MHC- 
congenic strains of mice (16). Analysis of these mice support 
a role for I-Ak-mediated deletion of V317 + T cells. Thus, 
in VB17-expressing B10.A(4R)~t mice (I-A  ~, I-E-), the per- 
centage of V317 +  T  cells was  reduced,  compared with 
C57/L mice (I-A  b, I-E-), and the low frequency of V317 + 
T cells was dominant in I-Ab/I-A  k heterozygous mice, con- 
sistent with donal deletion. These data are in agreement with 
our finding that  at  least  some VB17  §  T  cells recognize 
vSAG-9 in the context of I-A  k.  In support  of this,  recent 
data has shown that V317 + T cells interact with additional 
MMTV encoded superantigens presented in association with 
I-A molecules (17). 
It is not clear why only some (20 of 41) of the VB17 + 
T  cell hybridomas responded to the vSAG-9  + spleen cells. 
The lack of response was not due to either low levels of CD4 
or TCR, nor to an inability to produce II:2. Moreover, the 
hybridomas all responded strongly to SED illustrating that 
they are able to respond to at least some superantigens. One 
possible explanation,  predicted by our model, is that these 
hybridomas recognize vSAG-9 in the context of MHC mole- 
cules other than either H-2  d or H-2  ~. In support of this, the 
original typing of these hybridomas revealed  reactivity to spleen 
cells of haplotypes  not tested here, such as I-Ead3  s (6). 
Taken together, these studies illustrate a central role of class 
II molecules in presenting retroviral superantigens to T cells. 
It is likely that each component of the class II/TCRAuper- 
antigen trimolecular complex interacts with the other two 
components, and that each of these interactions contributes 
to the overall avidity of the complex. The interactions  be- 
tween TCR and class II may play a major role in T cell rec- 
ognition of superantigen if the association between class II 
and superantigen  and/or superantigen  and TCK is weak. 
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